On May 1, 2022, Analytical Biosciences is pleased to announce that Dr. Dongxiao (Tony) Zhang, a veteran of the life sciences and pharmaceutical industry, joins as Chief Executive Officer of Abiosciences Inc., who will lead company’s single cell genomics partnership and services, sales and marketing, and corporate development.
Go toMarch 1, 2022, Analytical BioSciences (Abio) is pleased to announce that Dr. Su Zhang, a life sciences and pharmaceutical industry veteran, joins Abio as Vice President, Global Head of BD and Strategy. She will lead the pharmaceutical and biotechnology business partnerships and strategic development for the company.
Go toDr. Xiaodong Andy Huang, Senior Vice President of Analytical BioSciences (Abio), is promoted to Chief Scientific Officer (CSO) to lead the company's overall drug R&D work, also will lead the Shanghai Discovery and Development Center to continuously improve the company's drug R&D capabilities and further accelerate the development of our innovative drug pipeline and discovery platforms.
Go toJan 21th, 2022, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Xinchun Chen’s group in Shenzhen University School of Medicine, has published a paper about tuberculous pleural effusion (TPE) in Journal of Experimental Medicine. Abio made great contributions to the single-cell data analysis part of the study.
Go toOn December 21, 2021, Analytical BioSciences, a single-cell genomics and discovery company, released OmniBrowser™ v3.1, a new version of OmniBrowser™, providing more data and tools for single-cell data visualization and analysis to further empower innovative drug discovery and development.
Go toOn December 17, 2021, the research group led by Prof. Zemin Zhang, a researcher at Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, and Beijing Advanced Innovation Center for Genomics (ICG) of Peking University, the founder of Analytical BioSciences, published an article on Science, revealed pan-cancer single cell landscape of tumor-infiltrating T cells.
Go toWe are happy to announce that Abiosciences, our branch in CA has got the certification for Visium Spatial Solutions from 10x Genomics.
Go toOct 14th, 2021, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Zhihua Liu’s group in Cancer Hospital of Chinese Academy of Medical Sciences, in close collaborations with Prof. Zemin Zhang’s group in Biomedical Pioneering Innovation Center of Peking University, has published a paper today about triple-negative breast cancer (TNBC) in Cancer Cell, a well-known academic journal in cancer research. Abio made great contributions to the single-cell sequencing experimental part of the study.
Go toOn September 25, Beijing Science and Technology Award(2020)was publicly announced. Professor Zemin Zhang, a researcher at Biomedical Pioneering Innovation Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG) of Peking University, the founder of Analytical BioSciences (Abio), won the first prize of the Natural Science Award for the project "Single Cell Atlas of Tumor Infiltrating T Cells".
Go toOn September 26th, 2021, Analytical BioSciences (Abio), a leader in single cell genomics, held the opening ceremony of its Shanghai R&D Center. Prof. Zemin Zhang, founder and scientific advisor of Abio, Mr. Tao Hong, co-founder and chief operation officer of Abio, Dr. Xiaodong Andy Huang, Senior Vice President of Abio, official leader of Xuhui District, representatives of investors including IDG Capital, Sequoia Capital China and SoftBank China
Go toAnalytical Biosciences and MemVerge implement world’s first Big Memory Computing environment for genomics research to fight cancer and stop the spread of COVID-19
Go toOn September 2nd, 2021, Analytical BioSciences releases a one-stop single-cell data analysis software, OmniAnalyzer®. OmniAnalyzer® is a standalone software for single cell multi-omics data analysis on code-free interface, enabling interactive data visualizations and generating publishable results.
Go toWe are happy to announce that we have reached a commercial agreement with the Human Cell Atlas (HCA) to help empower science discoveries of HCA collaborating members by providing #SingleCell sequencing and data analysis solutions, software and platform at a favorable price.
Go toMay 25 2021, Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round.
Go toOn May 1st, drug discovery expert and cancer biologist, Dr. Xiaodong Andy Huang joins Analytical BioSciences as senior vice president, leading the drug development of the company.
Go toRecently, Elsevier released the 2020 Highly Cited Chinese Researchers list. Professor Zemin Zhang and Professor Fuchou Tang of Peking University, both scientific advisors of Analytical BioSciences, were selected in the list.
Go toRecently, Stanford University released a list of World's Top 2% Scientists 2020. Among them, Professor Zemin Zhang and Professor Fuchou Tang of Peking University, both scientific advisors of Analytical BioSciences, was selected as the "Annual Impact" list of the top 2% of the world's top scientists in 2020.
Go toFeb 18, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Genome Biology titled “iMAP: integration of multiple single-cell datasets by adversarial paired transfer networks”,This seminal work is a collaborative effort between Zhang Lab at Peking University and Analytical BioSciences.
Go toFebruary 9, 2021 Beijing – Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, announced today of an investment from and a strategic joint effort with BioMap, a AI-powered Life Sciences Company initiated and founded by Baidu’s founder Robin Li, to develop commercial analytical platforms and big data infrastructure for applications of single cell genomics in biomedical fields and develop a single-cell + AI innovation ecosystem.
Go toFeb 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that its founder and scientific advisor,Professor Zemin Zhang of Peking University, has published three seminal papers this week on Covid-19 and Cancer Immunology.
Go toFeb 4, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Cell titled “A Pan-Cancer Single-Cell Transcriptional Atlas of Tumor Infiltrating Myeloid Cells”.
Go toFeb 3, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a paper on Covid-19.
Go toFeb 2, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Nature Communications titled “Tumour Heterogeneity and Intercellular Networks of Nasopharyngeal Carcinoma at Single Cell Resolution”.
Go toOn January 4, 2021, Analytical BioSciences, a single-cell genomics and discovery company, launched OmniBrowserTM, a comprehensively curated single cell data compendium with visualization and analysis capabilities that further empower innovative drug discovery and development.
Go toIn Oct 2020, Analytical BioSciences and 10x Genomics reach cooperation in single-cell sequencing analysis, Analytical BioSciences becomes a validated partner in CPP(Compatible Partner Program)of 10x Genomics. Since then, Analytical BioSciences will provide cutting-edge single-cell sequencing data analysis for 10x Genomics and its client.
Go toIn Oct 2020, Analytical BioSciences and 10x Genomics reach cooperation in single-cell sequencing analysis, Analytical BioSciences becomes a validated partner in CPP(Compatible Partner Program)of 10x Genomics. Since then, Analytical BioSciences will provide cutting-edge single-cell sequencing data analysis for 10x Genomics and its client.
Go toOn October 22, 2020, the scientific advisor of Analytical Biosciences, Prof. FuChou Tang and his research group published an article on Cancer Cell, titled with “Single-Cell Multiomics Sequencing Reveals Prevalent Genomic Alterations in Tumor Stromal Cells of Human Colorectal Cancer”, together with Wei Fu’s group, provides evidence and functional relevance of pervasive genomic alterations in the stromal cells of tumor microenvironment in Colorectal Cancer.
Go toOn June 22th, Analytical BioSciences and Professor Zemin Zhang's research group published a bioinformatics methodology paper on Nature Communications, titled " An entropy-based metric for assessing the purity of single cell populations ", officially released ROGUE, a new tool for unsupervised gene selection and cell group purity assessment based on single-cell transcriptome data.
Go toOn June 15, 2020, the founder and scientific adviser of Analytical Biosciences,Professor Zemin Zhang and his group published a paper on Cell Research, title with "Reconstruction of cell spatial organization from single-cell RNA sequencing data based on ligand-receptor". The paper present a new algorithm for cell spatial relationships based on cell interaction, CSOmap.
Go toOn April 16, the founder and scientific adviser of Analytical BioSciences, Professor Zemin Zhang and his research group published an article on Cell with collaborators,titled "Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies In Colon Cancer", which systematically characterized the tumor microenvironment of patients with colorectal cancer by using single-cell transcriptome sequencing,especially the infiltrating myeloid cell group for the first time. Meanwhile, it uses a mouse model to explain the potential mechanism of immunotherapeutic strategies of anti-CD40 agonists and anti-CSF1R inhibitor targeting myeloid cells.
Go toOn April 14th, Analytical BioSciences and Professor Zemin Zhang's research group published a bioinformatics methodology paper on Nature Communications, titled "SciBet as a portable and fast single cell type identifier ", officially released SciBet, a new tool for fast and supervised cell type annotation based on single-cell transcriptome data.
Go toApril 17, 2020: Dr. Yuelan Wang joined Abiosciences as the Vice President, leading the research and development of the company's bioinformatics software department.
Go toOn March 16th, 2020, 8 companies, including Analytical BioSciences, MGI, Geneplus, iGeneTech, WeGene, NextOmics, TSINGKE, IGENECODE, form the Domestic Sequencing Platform Application Ecological Alliance. By the alliance, members will provide the more competitive products and services to customers in various segments of the industry by cooperation, creating a new ecology for the Chinese gene industry.
Go toThe research group of Professor Zemin Zhang, the founder and scientific consultant of Analytical Biosciences, has made a pioneering breakthrough of hepatocellular carcinoma. On February 16, 2020, the research was recognized in Top Ten Advances in Bioinformatics of China 2019 recognized by the peer reviewers organized by Genomics, Proteomics and Bioinformatics (GPB) journal.
Go toOn Feb 23, 2020, the founder of Analytical Biosciences, Professor Zemin Zhang, was invited to attend the Hanhai BioTalk series of lectures, and was interviewed by Dr. Zhang Jian, the chief scientist of Hanhai, talking about "single cell research and application of disease tissue".
Go toOn January 30, 2020, the scientific advisor of Analytical Biosciences, Prof. FuChou Tang and his research group published a cover article on Cell entitled “Single-Cell Transcriptomic Atlas of Primate Ovarian Aging”, together with Guanghui Liu’s group and other collaborative teams, revealed the aging mechanism of primate ovarian.
Go toOn February 5, the founder and scientific advisor of Analytical Biosciences, Professor Zemin Zhang and his research group published a paper on Nature entitled "Genomic basis for RNA alterations in cancer" ,together with Alvis Brazma, Angela Brooks, Gunnar Rätsch and other collaborating teams. The research paper reports major advances in the field of tumor transcriptome alteration.
Go toRecently, a new subsidiary journal of Nature, Nature Cancer was officially launched. It invited 10 leading scientists who approach cancer from diverse perspectives to ask them about the key developments in their fields and what their envision will be the next breakthroughs in cancer and published the first issue “A roadmap for the next decade in cancer research”.
Go toOn December 17, 2019, Analytical Biosciences celebrates its first birthday.
Go toOn October 24, 2019, Analytical BioSciences Limited received the official notification of 10x Genomics, and was approved as a 10x Genomics Certified Service Provider for the Chromium Single Cell Immune Profiling Solution. Analytical BioSciences also obtained the official certification from 10x Genomics for the Single Cell 5' gene expression and VDJ analysis. This was the first time that 10x Genomics certified this technology to an institution in China. Therefore, Analytical BioSciences becomes the only domestic institution that has been certified by 10x Genomics for single cell immune profiling.
Go toFrom October 20th to 21st,the ‘Single Cell Omics Beijing 2019 Symposium’ co-sponsored by Beijing Advanced Innovation Center for Genomics (ICG) and Biomedical Pioneering Innovation Center (BIOPIC), was held in Qiulin lecture hall of Peking University. Analytical Biosciences participated in the symposium as a major sponsor, attracting many teachers and students and promoted heated discussions by its single cell sequencing and analysis technology.
Go toOn June 17, the appointment ceremony of scientific advisors of Analytical Biosciences took place in the Beijing office. Analytical Biosciences invited Professor Runsheng Chen from Institute of Biophysics of the Chinese Academy of Sciences, Professor Fuchou Tang from Peking University, and Professor Zemin Zhang from Peking University to join its Scientific Advisory Board. The goal of these appointment is to advance the research and technology capacities and to enhance the impact of single-cell sequencing and bioinformatics.
Go toOn June 29, 2019, the fifth precision medicine and gene sequencing conference was held in the academic hall of Peking Union Medical College. The conference was co-sponsored by seqChina, Peking Union Medical College Hospital and Beijing Medical Award Foundation. Prof. Runsheng Chen and Prof. Zemin Zhang were invited to attend the conference and presented the plenary lectures, which received extensive attention, discussion and recognition from the participants.
Go toOn the June 10, Mr. Boxi Kang, head of the Bioinformatics Department of Analytical Biosciences, gave a lecture entitled “A Framework for Real-time Analysis and Visualization of Large Single-cell RNA-seq Data” on the Cold Spring Harbor Asia Conference (Suzhou) on the Scientific and Technical Advances in Cancer Immunology.
Go to© Analytical Biosciences Limited. All rights reserved.